வாழ்க்கை அறிவியல் பரிசோதனை சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வாழ்க்கை அறிவியல் பரிசோதனை சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வாழ்க்கை அறிவியல் பரிசோதனை சங்கம் Today - Breaking & Trending Today

ProMIS Neurosciences Inc.: ProMIS Neurosciences initiates commercialization of COVID-19 serology assay

ProMIS Neurosciences Inc.: ProMIS Neurosciences initiates commercialization of COVID-19 serology assay
Seasoned industry executive and entrepreneur, Owen Dempsey to lead the effort for ProMIS
TORONTO and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced that it has initiated commercialization of its COVID-19 serology assay and has appointed Owen Dempsey to lead the commercialization program.
Owen s professional work for the past 25 years has been to build companies founded to discover and commercialize antibodies in applications including life science research, pharmaceutical drug discovery, clinical diagnostics and therapeutic treatment of cancer, AIDS and other serious illness. He has led private, venture-backed ....

United Kingdom , United States , Bowen Dempsey , Nicholas Rigopulos , Toronto Stock Exchange , Promis Neurosciences Inc , Life Science Diagnostics Association , Life Science , Collective Coordinates , Disease Specific Epitopes , Investor Relations , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஓவந் டெம்ப்சே , டொராண்டோ ஸ்டாக் பரிமாற்றம் , ப்ரோமிச் நரம்பியல் இன்க் , வாழ்க்கை அறிவியல் பரிசோதனை சங்கம் , வாழ்க்கை அறிவியல் , கூட்டு ஆய அச்சுகள் , முதலீட்டாளர் உறவுகள் ,

Celebrating 75 years: A conversation with Eppendorf CEOs Eva van Pelt and Peter Fruhstorfer

Hamburg, Germany
Dr. Fruhstorfer has been Co-CEO of the Management Board of Eppendorf AG since December 2019 and is also responsible for the business portfolio He has been head of the Sample Handling Division since 2018. He held various management positions at Thermo Fisher Scientific in the Netherlands, the FEI Company in the USA, and in various countries for the Carl Zeiss Group. He has a doctorate in chemistry from the technical University Munich, Germany.
Sean Sanders, Ph.D.
Washington, DC
Dr. Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph.D. at the University of Cambridge, UK, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined BioTechniques as an editor, ....

Nordrhein Westfalen , Leica Microsystems , Dutch Chamber , Life Science Diagnostics Association , Management Board , Hitachi Data Systems , German Dutch Chamber , Life Science , Diagnostics Association , Supervisory Boards , Ludwig Maximilians University Munich , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , லைக்கா மைக்ரோசிஸ்டம்ஸ் , டச்சு அறை , வாழ்க்கை அறிவியல் பரிசோதனை சங்கம் , மேலாண்மை பலகை , ஹிட்டாச்சி தகவல்கள் அமைப்புகள் , ஜெர்மன் டச்சு அறை , வாழ்க்கை அறிவியல் , பரிசோதனை சங்கம் , மேற்பார்வை பலகைகள் , லுட்விக் அதிகபட்சம் பல்கலைக்கழகம் முனிச் ,